The global Pharmaceutical Dissolution Testing Services Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Method (In vitro, In vivo), By Dosage Form (Capsule, Tablets, Others), By Dissolution Apparatus (Basket, Paddle, Others).
In 2024, the pharmaceutical dissolution testing services market is thriving, fueled by the increasing regulatory scrutiny of drug dissolution profiles, advancements in dissolution testing methodologies, and the demand for outsourcing solutions to support drug development and quality control processes. Dissolution testing services assess the rate and extent of drug release from pharmaceutical dosage forms such as tablets, capsules, and suspensions, providing critical information on drug formulation performance, bioavailability, and batch-to-batch consistency. With advancements in automation, analytical instrumentation, and data analysis tools, the market is experiencing rapid expansion and adoption of dissolution testing services, offering pharmaceutical companies reliable and compliant solutions for product development, formulation optimization, and regulatory submissions.
A prominent trend in the Pharmaceutical Dissolution Testing Services Market is the increasing emphasis on quality control and compliance. As regulatory requirements become more stringent, pharmaceutical companies are prioritizing robust dissolution testing to ensure the efficacy, safety, and consistency of their drug products. This trend is driving the outsourcing of dissolution testing services to specialized contract research organizations (CROs) and testing laboratories equipped with state-of-the-art equipment and expertise in dissolution testing methodologies, helping pharmaceutical companies maintain regulatory compliance and product quality.
A key driver fueling the Pharmaceutical Dissolution Testing Services Market is the rising demand for generic drugs and biosimilars. With the expiration of patents for numerous branded drugs, the generic drug market is experiencing significant growth globally, driving the need for dissolution testing services to assess the equivalence of generic formulations to their branded counterparts. Additionally, the increasing development and approval of biosimilars necessitate thorough dissolution testing to demonstrate similarity and comparability with reference biologics, driving the demand for dissolution testing services among pharmaceutical manufacturers and developers.
An opportunity within the Pharmaceutical Dissolution Testing Services Market lies in the adoption of advanced analytical techniques and automation. As pharmaceutical companies seek to enhance efficiency, accuracy, and throughput in dissolution testing, there is a growing demand for innovative solutions such as automated dissolution testing systems, high-throughput screening platforms, and advanced analytical instrumentation, including spectroscopy and chromatography. CROs and testing laboratories offering cutting-edge dissolution testing capabilities and automation solutions can capitalize on this opportunity by providing faster turnaround times, higher throughput, and improved data quality, thereby gaining a competitive edge in the market.
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Agilent Technologies Inc
Almac Group
AMRI
Avivia BV
Boston Analytical
Cambrex
Catalent Inc
Charles River Laboratories
Intertek Group Plc.
Pace Analytical Life Sciences
SGS SA
SOTAX
Thermofisher Scientific Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Pharmaceutical Dissolution Testing Services Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Pharmaceutical Dissolution Testing Services Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Pharmaceutical Dissolution Testing Services Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Pharmaceutical Dissolution Testing Services Market Size Outlook, $ Million, 2021 to 2030
3.2 Pharmaceutical Dissolution Testing Services Market Outlook by Type, $ Million, 2021 to 2030
3.3 Pharmaceutical Dissolution Testing Services Market Outlook by Product, $ Million, 2021 to 2030
3.4 Pharmaceutical Dissolution Testing Services Market Outlook by Application, $ Million, 2021 to 2030
3.5 Pharmaceutical Dissolution Testing Services Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Pharmaceutical Dissolution Testing Services Industry
4.2 Key Market Trends in Pharmaceutical Dissolution Testing Services Industry
4.3 Potential Opportunities in Pharmaceutical Dissolution Testing Services Industry
4.4 Key Challenges in Pharmaceutical Dissolution Testing Services Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Pharmaceutical Dissolution Testing Services Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Pharmaceutical Dissolution Testing Services Market Outlook by Segments
7.1 Pharmaceutical Dissolution Testing Services Market Outlook by Segments, $ Million, 2021- 2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
8 North America Pharmaceutical Dissolution Testing Services Market Analysis and Outlook To 2030
8.1 Introduction to North America Pharmaceutical Dissolution Testing Services Markets in 2024
8.2 North America Pharmaceutical Dissolution Testing Services Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Pharmaceutical Dissolution Testing Services Market size Outlook by Segments, 2021-2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
9 Europe Pharmaceutical Dissolution Testing Services Market Analysis and Outlook To 2030
9.1 Introduction to Europe Pharmaceutical Dissolution Testing Services Markets in 2024
9.2 Europe Pharmaceutical Dissolution Testing Services Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Pharmaceutical Dissolution Testing Services Market Size Outlook by Segments, 2021-2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
10 Asia Pacific Pharmaceutical Dissolution Testing Services Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Pharmaceutical Dissolution Testing Services Markets in 2024
10.2 Asia Pacific Pharmaceutical Dissolution Testing Services Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Pharmaceutical Dissolution Testing Services Market size Outlook by Segments, 2021-2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
11 South America Pharmaceutical Dissolution Testing Services Market Analysis and Outlook To 2030
11.1 Introduction to South America Pharmaceutical Dissolution Testing Services Markets in 2024
11.2 South America Pharmaceutical Dissolution Testing Services Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Pharmaceutical Dissolution Testing Services Market size Outlook by Segments, 2021-2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
12 Middle East and Africa Pharmaceutical Dissolution Testing Services Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Pharmaceutical Dissolution Testing Services Markets in 2024
12.2 Middle East and Africa Pharmaceutical Dissolution Testing Services Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Pharmaceutical Dissolution Testing Services Market size Outlook by Segments, 2021-2030
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Almac Group
AMRI
Avivia BV
Boston Analytical
Cambrex
Catalent Inc
Charles River Laboratories
Intertek Group Plc.
Pace Analytical Life Sciences
SGS SA
SOTAX
Thermofisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Method
In vitro
In vivo
By Dosage Form
Capsule
Tablets
Others
By Dissolution Apparatus
Basket
Paddle
Others
The global Pharmaceutical Dissolution Testing Services Market is one of the lucrative growth markets, poised to register a 8.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Agilent Technologies Inc, Almac Group, AMRI, Avivia BV, Boston Analytical, Cambrex, Catalent Inc, Charles River Laboratories, Intertek Group Plc., Pace Analytical Life Sciences, SGS SA, SOTAX, Thermofisher Scientific Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume